Retirement Planning Co of New England, Inc.
PensionPosition in JNJ — Johnson & Johnson
CIK 1817693
Warwick, RI
Position in JNJ
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,408,009
-$45,920 QoQ
Shares Held
5,544
-6.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#2,659
of 4,664 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Dec 31, 2022CallValue
$17,665
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Retirement Planning Co of New England, Inc. holds $14,749,439 across 10 Drug Manufacturers - General names. JNJ ranks #4 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
20,235 | $5,091,935 | |
| 2 | LLY |
ELI LILLY & Co
|
2,403 | $2,882,230 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
11,227 | $1,418,419 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
5,544 | $1,408,009 | |
| 5 | MRK |
Merck & Co., Inc.
|
10,597 | $1,361,714 | |
| 6 | NVO |
Novo Nordisk A S
|
14,140 | $677,871 | |
| 7 | PFE |
Pfizer Inc
|
28,045 | $675,323 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
10,883 | $627,078 |
All Filings in JNJ
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,408,009 | 5,544 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,453,929 | 5,948 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,210,450 | 5,849 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $1,110,294 | 5,988 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $894,198 | 5,854 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $985,918 | 5,945 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $759,978 | 5,255 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $790,042 | 4,875 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $726,561 | 4,971 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $795,695 | 5,030 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,103,292 | 7,039 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $975,618 | 6,264 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $989,975 | 5,981 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $923,180 | 5,956 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $17,665 | 100 | Call | Sole | 2023-02-03 | |
| 2022-12-31 | $1,028,986 | 5,825 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $939,973 | 5,754 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $964,766 | 5,435 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,064,975 | 6,009 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $990,837 | 5,792 | Shares | Sole | 2022-02-08 | |
| No filing history on record for this holder in this stock. | ||||||